HIV/AIDS
Data on HIV/AIDS reported by researchers at University of Amsterdam
Published in AIDS Weekly, January 7th, 2008
In this recent study, researchers in Netherlands conducted a study "To objectively assess changes in body fat distribution in a subgroup of antiretroviral therapy-naive participants in a randomized comparative trial of regimens including a nucleoside analogue backbone of didanosine with either lamivudine or stavudine. Whole body dual-energy X-ray absorptiometry (DEXA) scans were performed at baseline and weeks 48 and 96 of therapy in all 19 patients from one of the sites participating in the Antiretroviral Regimen Evaluation Study (ARES)."
"Patients had been randomized to receive nelfinavir/didanosine/stavudine (n = 8), nevirapine/didanosine/lamivudine (n = 7), or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-01-07)
More Articles from AIDS Weekly
- HIV/AIDS
New HIV/AIDS research from D.K. Mcmahon and colleagues discussed - HIV/AIDS
New research on HIV/AIDS from J. Arrizabalaga and co-authors summarized - HIV/AIDS
Reports summarize HIV/AIDS research from J. Sheldon and co-authors - HIV/AIDS
Research conducted at University of Liverpool has provided new information about HIV/AIDS - HIV/AIDS
Research from University of California yields new data on HIV/AIDS - HIV/AIDS
Researchers at Harvard University target HIV/AIDS - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
